好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | C180 - Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia

Wednesday 04/26/17
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Amanda C. Peltier, MD, MS
Participants should be able to improve their ability to formulate a differential diagnosis for functional autonomic disorders and a treatment plan for patients with common varieties of autonomic dysfunction.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic
Event Timeline
03:30 PM - 04:20 PM Speaker Diagnostic Approach to the Patient with Dysautonomia
William P. Cheshire, Jr., MD, FAAN
04:20 PM - 05:10 PM Speaker Treatments for Autonomic Failure and Dysautonomia
Amanda C. Peltier, MD, MS
05:10 PM - 05:30 PM Q&A Questions and Answers
Faculty Disclosures
William P. Cheshire, Jr., MD, FAAN Dr. Cheshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for oxford university press. Dr. Cheshire has a non-compensated relationship as a Associate Editor with Clinical Autonomic Research that is relevant to AAN interests or activities.
Amanda C. Peltier, MD, MS Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Csl Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Goldman Ismail. The institution of Dr. Peltier has received research support from NIH. The institution of Dr. Peltier has received research support from CSL Behring.